Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.12
OMI's Cash-to-Debt is ranked lower than
81% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.69 vs. OMI: 0.12 )
Ranked among companies with meaningful Cash-to-Debt only.
OMI' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.04 Max: 0.76
Current: 0.12
0
0.76
Equity-to-Asset 0.30
OMI's Equity-to-Asset is ranked lower than
74% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.47 vs. OMI: 0.30 )
Ranked among companies with meaningful Equity-to-Asset only.
OMI' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.21  Med: 0.36 Max: 0.47
Current: 0.3
0.21
0.47
Debt-to-Equity 0.89
OMI's Debt-to-Equity is ranked lower than
76% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.53 vs. OMI: 0.89 )
Ranked among companies with meaningful Debt-to-Equity only.
OMI' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.21  Med: 0.65 Max: 1.39
Current: 0.89
0.21
1.39
Debt-to-EBITDA 6.06
OMI's Debt-to-EBITDA is ranked lower than
87% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.37 vs. OMI: 6.06 )
Ranked among companies with meaningful Debt-to-EBITDA only.
OMI' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.86  Med: 1.35 Max: 6.06
Current: 6.06
0.86
6.06
Interest Coverage 4.02
OMI's Interest Coverage is ranked lower than
67% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.71 vs. OMI: 4.02 )
Ranked among companies with meaningful Interest Coverage only.
OMI' s Interest Coverage Range Over the Past 10 Years
Min: 4.02  Med: 13.68 Max: 15.45
Current: 4.02
4.02
15.45
Piotroski F-Score: 4
Altman Z-Score: 3.39
Beneish M-Score: -2.01
WACC vs ROIC
5.88%
4.75%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating Margin % 0.96
OMI's Operating Margin % is ranked lower than
68% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.60 vs. OMI: 0.96 )
Ranked among companies with meaningful Operating Margin % only.
OMI' s Operating Margin % Range Over the Past 10 Years
Min: 0.96  Med: 2.2 Max: 2.5
Current: 0.96
0.96
2.5
Net Margin % 0.78
OMI's Net Margin % is ranked lower than
69% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.61 vs. OMI: 0.78 )
Ranked among companies with meaningful Net Margin % only.
OMI' s Net Margin % Range Over the Past 10 Years
Min: 0.7  Med: 1.23 Max: 1.36
Current: 0.78
0.7
1.36
ROE % 7.26
OMI's ROE % is ranked lower than
54% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.39 vs. OMI: 7.26 )
Ranked among companies with meaningful ROE % only.
OMI' s ROE % Range Over the Past 10 Years
Min: 6.54  Med: 11.24 Max: 14.35
Current: 7.26
6.54
14.35
ROA % 2.44
OMI's ROA % is ranked lower than
61% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.37 vs. OMI: 2.44 )
Ranked among companies with meaningful ROA % only.
OMI' s ROA % Range Over the Past 10 Years
Min: 2.39  Med: 5.07 Max: 6.2
Current: 2.44
2.39
6.2
ROC (Joel Greenblatt) % 8.85
OMI's ROC (Joel Greenblatt) % is ranked lower than
66% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 23.17 vs. OMI: 8.85 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
OMI' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 8.85  Med: 24.78 Max: 30.56
Current: 8.85
8.85
30.56
3-Year Revenue Growth Rate 0.80
OMI's 3-Year Revenue Growth Rate is ranked lower than
70% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.70 vs. OMI: 0.80 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
OMI' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -0.5  Med: 4.4 Max: 34.7
Current: 0.8
-0.5
34.7
3-Year EBITDA Growth Rate -11.60
OMI's 3-Year EBITDA Growth Rate is ranked lower than
67% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 7.10 vs. OMI: -11.60 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
OMI' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -15.5  Med: 6.4 Max: 37.6
Current: -11.6
-15.5
37.6
3-Year EPS without NRI Growth Rate 4.20
OMI's 3-Year EPS without NRI Growth Rate is ranked lower than
99.99% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.10 vs. OMI: 4.20 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
OMI' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -25.3  Med: 8.2 Max: 79.5
Current: 4.2
-25.3
79.5
GuruFocus has detected 6 Warning Signs with Owens & Minor Inc OMI.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» OMI's 30-Y Financials

Financials (Next Earnings Date: 2018-05-02)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2017

OMI Guru Trades in Q1 2017

Jim Simons 224,950 sh (New)
Steven Cohen 723,500 sh (+770.64%)
Paul Tudor Jones 27,723 sh (+35.75%)
Richard Pzena 1,579,596 sh (+18.83%)
Chuck Royce 760,670 sh (+5.99%)
Barrow, Hanley, Mewhinney & Strauss 210,842 sh (+3.47%)
Mario Gabelli 193,650 sh (unchged)
Charles Brandes 24,732 sh (unchged)
Pioneer Investments 574,485 sh (-0.73%)
Joel Greenblatt 306,518 sh (-16.79%)
» More
Q2 2017

OMI Guru Trades in Q2 2017

Caxton Associates 18,508 sh (New)
David Dreman 948 sh (New)
Charles Brandes 150,584 sh (+508.86%)
Jim Simons 542,750 sh (+141.28%)
Barrow, Hanley, Mewhinney & Strauss 219,306 sh (+4.01%)
Mario Gabelli 193,650 sh (unchged)
Pioneer Investments 574,485 sh (unchged)
Paul Tudor Jones Sold Out
Steven Cohen Sold Out
Joel Greenblatt Sold Out
Richard Pzena 1,567,412 sh (-0.77%)
Chuck Royce 728,670 sh (-4.21%)
» More
Q3 2017

OMI Guru Trades in Q3 2017

Charles Brandes 199,515 sh (+32.49%)
Richard Pzena 1,617,568 sh (+3.20%)
Mario Gabelli 193,650 sh (unchged)
David Dreman 948 sh (unchged)
Caxton Associates Sold Out
Barrow, Hanley, Mewhinney & Strauss 218,296 sh (-0.46%)
Pioneer Investments 343,738 sh (-40.17%)
Chuck Royce 316,070 sh (-56.62%)
Jim Simons 25,750 sh (-95.26%)
» More
Q4 2017

OMI Guru Trades in Q4 2017

HOTCHKIS & WILEY 43,367 sh (New)
Charles Brandes 1,451,863 sh (+627.70%)
Jim Simons 93,850 sh (+264.47%)
Chuck Royce 759,386 sh (+140.26%)
Mario Gabelli 193,650 sh (unchged)
David Dreman 948 sh (unchged)
Richard Pzena 1,601,913 sh (-0.97%)
Barrow, Hanley, Mewhinney & Strauss 200,714 sh (-8.05%)
Pioneer Investments 263,914 sh (-23.22%)
» More
» Details

Insider Trades

Latest Guru Trades with OMI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Richard Pzena 2017-12-31 Reduce -0.97%$18.1 - $29.64 $ 16.08-28%1,601,913
Charles Brandes 2017-12-31 Add 627.70%0.47%$18.1 - $29.64 $ 16.08-28%1,451,863
Barrow, Hanley, Mewhinney & Strauss 2017-12-31 Reduce -8.05%$18.1 - $29.64 $ 16.08-28%200,714
HOTCHKIS & WILEY 2017-12-31 New Buy$18.1 - $29.64 $ 16.08-28%43,367
Richard Pzena 2017-09-30 Add 3.20%0.01%$27.07 - $32.51 $ 16.08-46%1,617,568
Barrow, Hanley, Mewhinney & Strauss 2017-09-30 Reduce -0.46%$27.07 - $32.51 $ 16.08-46%218,296
Charles Brandes 2017-09-30 Add 32.49%0.03%$27.07 - $32.51 $ 16.08-46%199,515
Richard Pzena 2017-06-30 Reduce -0.77%$31.49 - $34.8 $ 16.08-51%1,567,412
Barrow, Hanley, Mewhinney & Strauss 2017-06-30 Add 4.01%$31.49 - $34.8 $ 16.08-51%219,306
Charles Brandes 2017-06-30 Add 508.86%0.07%$31.49 - $34.8 $ 16.08-51%150,584
David Dreman 2017-06-30 New Buy0.02%$31.49 - $34.8 $ 16.08-51%948
Joel Greenblatt 2017-06-30 Sold Out 0.13%$31.49 - $34.8 $ 16.08-51%0
Richard Pzena 2017-03-31 Add 18.83%0.05%$33.9 - $36.95 $ 16.08-55%1,579,596
Joel Greenblatt 2017-03-31 Reduce -16.79%0.03%$33.9 - $36.95 $ 16.08-55%306,518
Barrow, Hanley, Mewhinney & Strauss 2017-03-31 Add 3.47%$33.9 - $36.95 $ 16.08-55%210,842
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Distribution » Medical Distribution    NAICS: 423450    SIC: 5047
Compare:SHSE:603368, TSE:7476, SHSE:600090, SZSE:002551, LSE:CLIN, NYSE:PMC, SHSE:600763, NZSE:EBO, ASX:SIG, ISX:EPMT, ASX:API, TSE:3183, HKSE:01011, NYSE:PBH, BSP:PFRM3, TPE:4164, ROCO:5312, TSE:7634, HKSE:02289, ASX:PGC » details
Traded in other countries:6OM.Germany,
Headquarter Location:USA
Owens & Minor Inc is a healthcare logistics firm distributing low-tech, consumable medical supplies to acute-care hospitals. The company distributes products to healthcare service providers under various brands such as MediChoice and ArcRoyal.

O&M distributes low-tech, consumable medical supplies to acute-care hospitals and other providers. The company distributes thousands of products produced by more than 1,200 suppliers to about 4,000 healthcare providers.

Top Ranked Articles about Owens & Minor Inc

10 Stocks Richard Pzena Continues to Buy Guru increased these holdings in the last 2 quarters
Richard Pzena (Trades, Portfolio), founder and co-chief investment officer of Pzena Investment Management, purchased shares of the following stocks in first-quarter 2017 and fourth-quarter 2016. Read more...

Ratios

vs
industry
vs
history
PE Ratio 13.40
OMI's PE Ratio is ranked higher than
82% of the 57 Companies
in the Global Medical Distribution industry.

( Industry Median: 18.85 vs. OMI: 13.40 )
Ranked among companies with meaningful PE Ratio only.
OMI' s PE Ratio Range Over the Past 10 Years
Min: 12.98  Med: 19.85 Max: 36
Current: 13.4
12.98
36
Forward PE Ratio 7.96
OMI's Forward PE Ratio is ranked higher than
93% of the 15 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.48 vs. OMI: 7.96 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 13.40
OMI's PE Ratio without NRI is ranked higher than
81% of the 57 Companies
in the Global Medical Distribution industry.

( Industry Median: 18.85 vs. OMI: 13.40 )
Ranked among companies with meaningful PE Ratio without NRI only.
OMI' s PE Ratio without NRI Range Over the Past 10 Years
Min: 12.98  Med: 19.57 Max: 36
Current: 13.4
12.98
36
PB Ratio 0.97
OMI's PB Ratio is ranked higher than
86% of the 65 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.32 vs. OMI: 0.97 )
Ranked among companies with meaningful PB Ratio only.
OMI' s PB Ratio Range Over the Past 10 Years
Min: 0.94  Med: 2.2 Max: 3.1
Current: 0.97
0.94
3.1
PS Ratio 0.10
OMI's PS Ratio is ranked higher than
95% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.88 vs. OMI: 0.10 )
Ranked among companies with meaningful PS Ratio only.
OMI' s PS Ratio Range Over the Past 10 Years
Min: 0.1  Med: 0.23 Max: 0.29
Current: 0.1
0.1
0.29
Price-to-Free-Cash-Flow 157.65
OMI's Price-to-Free-Cash-Flow is ranked lower than
100% of the 33 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.77 vs. OMI: 157.65 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
OMI' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 5.38  Med: 19.69 Max: 1972.67
Current: 157.65
5.38
1972.67
Price-to-Operating-Cash-Flow 16.94
OMI's Price-to-Operating-Cash-Flow is ranked lower than
65% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.21 vs. OMI: 16.94 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
OMI' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 4.92  Med: 15.03 Max: 62.94
Current: 16.94
4.92
62.94
EV-to-EBIT 19.96
OMI's EV-to-EBIT is ranked higher than
64% of the 70 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.77 vs. OMI: 19.96 )
Ranked among companies with meaningful EV-to-EBIT only.
OMI' s EV-to-EBIT Range Over the Past 10 Years
Min: 8  Med: 11.7 Max: 23.7
Current: 19.96
8
23.7
EV-to-EBITDA 11.98
OMI's EV-to-EBITDA is ranked higher than
82% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.79 vs. OMI: 11.98 )
Ranked among companies with meaningful EV-to-EBITDA only.
OMI' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.1  Med: 9.5 Max: 16.4
Current: 11.98
7.1
16.4
EV-to-Revenue 0.19
OMI's EV-to-Revenue is ranked higher than
87% of the 70 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.60 vs. OMI: 0.19 )
Ranked among companies with meaningful EV-to-Revenue only.
OMI' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.2  Med: 0.3 Max: 0.3
Current: 0.19
0.2
0.3
Shiller PE Ratio 9.41
OMI's Shiller PE Ratio is ranked higher than
89% of the 28 Companies
in the Global Medical Distribution industry.

( Industry Median: 29.39 vs. OMI: 9.41 )
Ranked among companies with meaningful Shiller PE Ratio only.
OMI' s Shiller PE Ratio Range Over the Past 10 Years
Min: 9.11  Med: 22.72 Max: 34.4
Current: 9.41
9.11
34.4
Current Ratio 1.67
OMI's Current Ratio is ranked higher than
62% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.60 vs. OMI: 1.67 )
Ranked among companies with meaningful Current Ratio only.
OMI' s Current Ratio Range Over the Past 10 Years
Min: 1.59  Med: 1.9 Max: 2.66
Current: 1.67
1.59
2.66
Quick Ratio 0.91
OMI's Quick Ratio is ranked lower than
65% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.12 vs. OMI: 0.91 )
Ranked among companies with meaningful Quick Ratio only.
OMI' s Quick Ratio Range Over the Past 10 Years
Min: 0.66  Med: 0.97 Max: 1.41
Current: 0.91
0.66
1.41
Days Inventory 43.45
OMI's Days Inventory is ranked lower than
56% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 41.27 vs. OMI: 43.45 )
Ranked among companies with meaningful Days Inventory only.
OMI' s Days Inventory Range Over the Past 10 Years
Min: 34.59  Med: 35.96 Max: 43.45
Current: 43.45
34.59
43.45
Days Sales Outstanding 29.73
OMI's Days Sales Outstanding is ranked higher than
86% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 61.26 vs. OMI: 29.73 )
Ranked among companies with meaningful Days Sales Outstanding only.
OMI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 21.19  Med: 22.69 Max: 29.73
Current: 29.73
21.19
29.73
Days Payable 42.46
OMI's Days Payable is ranked lower than
76% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 62.55 vs. OMI: 42.46 )
Ranked among companies with meaningful Days Payable only.
OMI' s Days Payable Range Over the Past 10 Years
Min: 26.53  Med: 28.2 Max: 42.46
Current: 42.46
26.53
42.46

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 6.41
OMI's Dividend Yield % is ranked higher than
91% of the 69 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.50 vs. OMI: 6.41 )
Ranked among companies with meaningful Dividend Yield % only.
OMI' s Dividend Yield % Range Over the Past 10 Years
Min: 1.49  Med: 2.68 Max: 6.63
Current: 6.41
1.49
6.63
Dividend Payout Ratio 0.82
OMI's Dividend Payout Ratio is ranked lower than
74% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.28 vs. OMI: 0.82 )
Ranked among companies with meaningful Dividend Payout Ratio only.
OMI' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.33  Med: 0.53 Max: 0.94
Current: 0.82
0.33
0.94
3-Year Dividend Growth Rate 1.00
OMI's 3-Year Dividend Growth Rate is ranked lower than
75% of the 28 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.70 vs. OMI: 1.00 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
OMI' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 1  Med: 12.2 Max: 21.6
Current: 1
1
21.6
Forward Dividend Yield % 6.47
OMI's Forward Dividend Yield % is ranked higher than
91% of the 66 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.79 vs. OMI: 6.47 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 7.35
OMI's 5-Year Yield-on-Cost % is ranked higher than
83% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.24 vs. OMI: 7.35 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
OMI' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.71  Med: 3.08 Max: 7.61
Current: 7.35
1.71
7.61
3-Year Average Share Buyback Ratio 1.00
OMI's 3-Year Average Share Buyback Ratio is ranked higher than
83% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: -1.90 vs. OMI: 1.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
OMI' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -5.5  Med: -1.2 Max: 1.1
Current: 1
-5.5
1.1

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 8.42
OMI's Price-to-Tangible-Book is ranked lower than
86% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.53 vs. OMI: 8.42 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
OMI' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.55  Med: 4.02 Max: 184.21
Current: 8.42
1.55
184.21
Price-to-Intrinsic-Value-Projected-FCF 0.56
OMI's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
97% of the 29 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.46 vs. OMI: 0.56 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
OMI' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.55  Med: 1.42 Max: 3.98
Current: 0.56
0.55
3.98
Price-to-Median-PS-Value 0.45
OMI's Price-to-Median-PS-Value is ranked higher than
85% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.90 vs. OMI: 0.45 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
OMI' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.42  Med: 0.88 Max: 1.48
Current: 0.45
0.42
1.48
Price-to-Graham-Number 2.24
OMI's Price-to-Graham-Number is ranked lower than
85% of the 33 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.45 vs. OMI: 2.24 )
Ranked among companies with meaningful Price-to-Graham-Number only.
OMI' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.99  Med: 1.87 Max: 15.22
Current: 2.24
0.99
15.22
Earnings Yield (Greenblatt) % 5.01
OMI's Earnings Yield (Greenblatt) % is ranked higher than
66% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 7.10 vs. OMI: 5.01 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
OMI' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 4.2  Med: 8.5 Max: 12.4
Current: 5.01
4.2
12.4
Forward Rate of Return (Yacktman) % 6.95
OMI's Forward Rate of Return (Yacktman) % is ranked lower than
53% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.62 vs. OMI: 6.95 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
OMI' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 2.8  Med: 7.8 Max: 20.1
Current: 6.95
2.8
20.1

More Statistics

Revenue (TTM) (Mil) $9,318.28
EPS (TTM) $ 1.20
Beta0.79
Short Percentage of Float21.83%
52-Week Range $14.26 - 36.73
Shares Outstanding (Mil)61.25

Analyst Estimate

Dec18 Dec19
Revenue (Mil $) 10,420 10,419
EBIT (Mil $) 218 249
EBITDA (Mil $) 272 312
EPS ($) 2.11 2.37
EPS without NRI ($) 2.11 2.37
EPS Growth Rate
(Future 3Y To 5Y Estimate)
5.93%
Dividends per Share ($) 1.11 1.25

Piotroski F-Score Details

Piotroski F-Score: 44
Positive ROAY
Positive CFROAY
Higher ROA yoyN
CFROA > ROAN
Lower Leverage yoyN
Higher Current Ratio yoyN
Less Shares Outstanding yoyY
Higher Gross Margin yoyY
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}